Strategic Partnership GraMedica has recently partnered with Lovell Government Services to bring HyProCure to VA, DoD, and IHS, signaling an opportunity to target government and defense hospital networks with their FDA-cleared EOTTS device.

Expansion Readiness With a collaboration-focused expansion into public sector channels and a growing footprint in medical facilities, there is potential to upsell integration services, training programs, and multi-site deployments for HyProCure and complementary foot health solutions.

Clinical Provenance HyProCure is backed by a substantial body of evidence (over 100 clinical studies) and strong patient outcomes (low complication rates), which can be leveraged in proof-of-value marketing, case studies, and pilot programs to win hospital and clinic buy-in.

Foot Health Portfolio Complementary products like Osteo-WEDGE and Opti-Toe offer cross-sell opportunities to orthopedic foot-and-ankle surgeons, enabling bundled solutions or extended product diversity for hospitals and private clinics.

Financial Signals Moderate revenue range and a focused niche in medical devices indicate a gateway for mid-market targets such as midsize hospital systems, outpatient centers, and durable medical equipment distributors seeking unique, minimally invasive orthopedics solutions.